HIGHLIGHTS
SUMMARY
Two years into the pandemic, it is time to investigate whether the vaccines against this new virus were developed and deployed successfully and what the advantages and drawbacks were in the policy choices made along the trajectory of vaccine development and delivery. It offers an inter-disciplinary framework for pandemic-related vaccine development, deployment, and governance. Possible solutions are proposed, to foster collaboration between key actors: i.e., public health authorities, governments of industrialized and developing countries, and the vaccine industry. As a result, the world has at times of pandemics witnessed trade fights . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.